
HEDROS Biotechnology is a biotech startup focused on developing bacteriophage-based solutions to combat bacterial diseases in aquaculture, specifically targeting AHPND in shrimp. Their proprietary technology uses highly targeted bacteriophages formulated into effective delivery systems to eradicate pathogenic bacteria while preserving beneficial bacteria, offering an environmentally friendly alternative to antibiotics. The company leverages AI-driven software, PhageChooser, to create custom bacteriophage cocktails for precise disease control. With a multidisciplinary team of scientists and innovators, HEDROS aims to revolutionize disease control in aquaculture, supporting sustainable practices and the global demand for safe seafood.

HEDROS Biotechnology is a biotech startup focused on developing bacteriophage-based solutions to combat bacterial diseases in aquaculture, specifically targeting AHPND in shrimp. Their proprietary technology uses highly targeted bacteriophages formulated into effective delivery systems to eradicate pathogenic bacteria while preserving beneficial bacteria, offering an environmentally friendly alternative to antibiotics. The company leverages AI-driven software, PhageChooser, to create custom bacteriophage cocktails for precise disease control. With a multidisciplinary team of scientists and innovators, HEDROS aims to revolutionize disease control in aquaculture, supporting sustainable practices and the global demand for safe seafood.